Download Presentation: H5N1 & Seasonal Influenza in Indonesia

Influenza Summit World Asia marks the start of World Vaccine Congress 2013, 17th – 20th June in Singapore where we understand the public health impact of influenza in Asia and the implications of influenza viral evolution and global spread. The chairperson of the Indonesia Influenza Foundation, Cissy Kartasasmita, will be presenting on “Preventing zoonotic influenza infection through continued surveillance of …

Download: Development of ‘next’ generation of enterovirus vaccines against Hand, Foot and Mouth Disease in Asia

Big outbreaks of Hand Foot and Mouth Disease (HFMD) have been occuring in China since 2008. HFMD became the No. 1 reported infectious disease in China in 2011, more cases than those of hepatitis caused by all hepatitis viruses combined. At 2012’s World Vaccine Congress Asia, Shuo Shen, Chief Scientific Officer at Wuhan Institute of Biological Products at China National …

A Case Study – Design alternatives for vaccine facilities

On the second day of World Vaccine Congress Asia 2013, Mr. Klaus Hermansen will be sharing a case study on designing alternatives for vaccine facilities. He will be speaking on driving flexibility for vaccine production with facility standardisation, designing approaches to reduce cost of goods as well as examining successful facility design case studies. Mr. Hermansen is currently the senior …

Hand, Foot, and Mouth Disease: Overcoming challenges of conducting clinical studies for HFMD vaccine

Mr. Zhu Fengcai will be one of the speakers present at World Vaccine Congress Asia 2013. He will be speaking on the topic of Hand, Foot, and Mouth Disease, specifically on overcoming challenges of conducting clinical studies for the HFMD vaccine. Mr. Zhu will be assessing the opportunities for conducting clinical trials for HFMD vaccine in Asia, and he will …

Herpes Zoster: Skin test with varicella-zoster virus antigen to predict risk of herpes zoster in population to advance herpes zoster vaccine development

While the vaccine for Herpes Zoster is a safe and effective preventive measure for reducing the overall burden and severity of HZ, the skin test with varicella-zoster virus antigen has been discovered as being an excellent surrogate for predicting the risk of Herpes Zoster. At the upcoming World Vaccine Congress Asia 2013, Mr. Yoshinobu Okuno will be speaking on the …

Developing effective vaccine strategies to launch promising new generation vaccine candidates

At the upcoming World Vaccine Congress Asia 2013, Mr. Ysuyuki Ishii will be joining us as one of the many speakers. Hear about developing effective vaccine strategies to launch promising new generation vaccine candidates as Mr. Ishii introduces alpha-galactosylceramide (GalCer), a ligand for invariant natural killer T (iNKT) cells bridging between innate and adaptive immunity. He will also be presenting …

Exploring learnings from the development of the AG129 mouse model of Dengue using suckling mouse brain

On the second day of the upcoming World Vaccine Congress Asia 2013, Mr. Manoj Kumar will be speaking on the topic "Exploring learnings from the development of the AG129 mouse model of Dengue using suckling mouse brain passages laboratory stocks of DEN viruses". The talk will cover examining the differences in the adaptation of suckling mouse brain stocks of the …

AIDS: Assessing opportunities and challenges in HIV vaccine development in Asia

Despite the availability of antiretroviral therapy for HIV/AIDS, treatment alone will not curtail the HIV/AIDS pandemic. Thus, developing a safe, effective and affordable vaccine that can prevent HIV infection in uninfected people is the best chance at controlling and possibly eliminating the AIDS epidemic. At the upcoming World Vaccine Congress Asia 2013, Mr. Rutt Chuachoowong will be speaking on the …

Advancing regulatory convergence in Asia with international standards

Dr. Der-Yuan Wang, one of the many speakers at World Vaccine Congress Asia 2013, will be speaking on the topic "Advancing regulatory convergence in Asia with international standards". His talk will cover unifying standards of quality, safety and efficacy of vaccines in Asia, developing national regulatory systems to strengthen capacities for vaccine approval, as well as accelerating regulatory approval processes …

Nonclinical safety assessment of vaccines, adjuvants, residuals and contaminants

The nonclinical safety assessment aims at identifying potential toxicities associated with the administration of vaccines to humans, and does play a critical role in ensuring vaccine safety. At the upcoming World Vaccine Congress Asia 2013, Dr. Lawrence Segal will be speaking on the topic "Nonclinical safety assessment of vaccines, adjuvants, residuals and contaminants". He will be focusing on how to …